<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib23">
 <element-citation publication-type="journal" id="sref23">
  <person-group person-group-type="author">
   <name>
    <surname>Fu</surname>
    <given-names>X.Q.</given-names>
   </name>
   <name>
    <surname>Chou</surname>
    <given-names>J.Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Yin</surname>
    <given-names>C.L.</given-names>
   </name>
   <name>
    <surname>Su</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Hossen</surname>
    <given-names>M.J.</given-names>
   </name>
  </person-group>
  <article-title>The JAK 2/STAT 3 pathway is involved in the anti‚Äêmelanoma effects of atractylenolide I</article-title>
  <source>Exp. Dermatol.</source>
  <volume>27</volume>
  <issue>2</issue>
  <year>2018</year>
  <fpage>201</fpage>
  <lpage>204</lpage>
  <pub-id pub-id-type="pmid">29078004</pub-id>
 </element-citation>
</ref>
